
    
      Subjects participating in this study will be respectively randomised (1:2:2:2) to receive
      either:

        -  placebo or

        -  escitalopram 20 mg/day or

        -  escitalopram 20 mg/day in combination with gaboxadol 5 mg/day or

        -  escitalopram 20 mg/day in combination with gaboxadol 10 mg/day
    
  